Namocatcat, Marites G.
HRN: 09-47-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFTAZIDIME 1GM (VIAL)
01/28/2025
02/04/2025
IVT
1 Gm
Q8H
DM FOOT
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes